Home
Companies
Shasqi

Shasqi

Y Combinator LogoW15ActiveBiotechTherapeutics

Pioneering Click Chemistry in Humans to make better cancer drugs

Our technology, based on click chemistry, enables the activation of small molecule drugs at the local tissue-level, improving both their efficacy and safety. The method is independent of endogenous cellular or environmental markers and allows the activation of drugs at a specific location for multiple weeks after the initial injection of the biomaterial at the desired site.

Shasqi
Founded:2015
Team Size:25
Location:San Francisco

Active Founders

Jose M. Mejia Oneto, CEO

José M Mejía Oneto is a physician scientist with training in Organic Chemistry at Emory and Orthopedics at UC Davis. During his clinical training, Jose recognized the need for a better way to get drugs to the right location in the body. Joined the YC program in 2015 with Tambo and in 2018 its spinoff Shasqi, focussing on pioneering click chemistry in humans for better cancer drugs. Shasqi has raised a more than $60M in funding, with its lead asset in Phase 2 and a growing pipeline of drugs.

Jose M. Mejia Oneto
Jose M. Mejia Oneto
Shasqi